ChartRow logo
IRMD
$88.24+0.67%
as of close, Oct 20, 2026
☾ AH $88.24 +0.67%
PeersMRNALLYMDTUNHJNJTMO
Share this page

IRMD financial statements

The full income statement, balance sheet, and cash-flow statement for iRadimed Corporation (IRMD), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 12.7M2024-09 12.7M2024-12 12.7M2025-03 12.7M2025-06 12.7M2025-09 12.7M2025-12 12.8M2026-03 12.8M2026-06 12.8M+0.9% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue83.8M+14.4%73.2M+11.7%65.6M+23.0%53.3M+27.5%41.8M+31.8%
64.3M+14.2%56.4M+12.3%50.2M+21.5%41.3M+28.8%32.0M+36.0%
Cost of revenue19.5M+15.4%16.9M+9.7%15.4M+28.1%12.0M+23.1%9.76M+19.9%
38.2M+11.0%34.4M+14.1%30.1M+17.4%25.7M+15.4%22.2M-8.6%
Research & development2.98M+5.0%2.83M-0.9%2.86M+25.5%2.28M+19.6%1.91M+0.1%
Selling, general & administrative17.8M+11.6%15.9M+5.4%15.1M+41.4%10.7M+9.5%9.77M-20.4%
General & administrative17.8M+11.6%15.9M+5.4%15.1M+41.4%10.7M+9.5%9.77M-20.4%
Selling & marketing17.4M+11.6%15.6M+28.6%12.1M-4.2%12.7M+20.1%10.6M+3.9%
Amortization of intangibles370K+59.5%232K+98.2%117K+15.7%101K-0.6%102K+9.5%
Provision for credit losses-84.0K+11.6%-95.0K-145.6%208K+102.7%103K+640.6%13.9K-50.2%
Operating income26.1M+19.0%22.0M+9.6%20.0M+28.2%15.6M+59.2%9.82M+1398.5%
Interest & investment income2.01M-8.4%2.19M+17.6%1.86M+220.4%582K+1571.7%34.8K-73.7%
Other non-operating income2.21M+1250.0%164K-90.4%1.70M+207.9%553K+2872.9%18.6K-86.6%
Pre-tax income28.4M+16.8%24.3M+11.7%21.7M+34.3%16.2M+64.5%9.84M+1694.5%
Income tax5.88M+16.7%5.04M+10.9%4.55M+35.6%3.35M+556.3%511K+125.7%
Net income22.5M+16.9%19.2M+11.9%17.2M+34.0%12.8M+37.6%9.33M+581.2%
$1.75+16.7%$1.50+11.1%$1.35+32.4%$1.02+37.8%$0.74+572.7%
EPS (basic)$1.77+16.4%$1.52+11.8%$1.36+33.3%$1.02+34.2%$0.76+590.9%
Weighted-avg shares (basic)12.7M+0.4%12.7M+0.5%12.6M+0.3%12.6M+1.8%12.3M+1.8%
Weighted-avg shares (diluted)12.9M+0.5%12.8M+0.5%12.7M+0.7%12.6M+0.4%12.6M+1.2%
Dividends per share$1.18+9.4%$1.08+3.0%$1.04+4.7%$1.00—
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
81.2M+7.9%75.2M-1.0%76.0M-1.9%77.5M+1.6%76.2M+19.6%
Cash & equivalents51.2M-2.1%52.2M+5.0%49.8M-14.1%58.0M-6.5%62.0M+23.8%
Accounts receivable13.7M+29.5%10.6M-13.6%12.2M-7.9%13.3M+158.4%5.14M+12.3%
Inventory11.6M+11.7%10.4M-18.9%12.8M+138.8%5.37M+24.9%4.30M+9.3%
Prepaid expenses1.65M-19.7%2.05M+71.8%1.19M+89.1%631K-36.9%1.00M+29.7%
109M+10.6%98.3M+6.7%92.2M+7.8%85.5M+3.2%82.9M+16.6%
Property, plant & equipment23.9M+41.9%16.8M+81.0%9.29M+287.1%2.40M+16.0%2.07M-2.4%
Operating lease right-of-use—155K-92.4%2.04M-7.4%2.21M-11.2%2.48M-8.6%
Intangible assets3.38M+9.2%3.10M+23.0%2.52M+21.7%2.07M+85.0%1.12M+16.4%
Deferred tax assets94.0K-96.7%2.82M+32.8%2.12M+202.9%701K-8.4%765K-39.9%
Other non-current assets239K-32.5%354K+95.1%181K-72.0%649K+222.2%201K-23.2%
10.2M+19.6%8.51M-47.9%16.3M+90.9%8.55M+25.4%6.82M+38.8%
Accounts payable1.82M-4.0%1.90M+2.1%1.86M+3.2%1.80M+129.8%783K+19.2%
Deferred revenue2.87M+27.0%2.26M-12.1%2.57M-23.8%3.37M+32.1%2.55M+31.0%
Current lease liability—153K-64.2%428K+45.8%293K+6.1%277K+8.2%
Other current liabilities313K-32.8%466K+86.4%250K—146K+0.0%
14.2M+23.0%11.5M-44.5%20.7M+75.1%11.8M+10.6%10.7M+10.6%
Deferred revenue (non-current)3.98M+32.9%2.99M+7.1%2.79M+103.1%1.38M-18.1%1.68M-27.2%
Non-current lease liability—2.00M+23.8%1.62M-15.5%1.91M-13.3%2.21M-10.3%
Operating lease liability (total)—155K-92.4%2.04M-21.8%2.61M+5.3%2.48M-8.6%
94.6M+9.0%86.8M+21.6%71.4M-3.1%73.7M+2.1%72.2M+17.6%
Common stock1.00K+0.0%1.00K-20.9%1.26K+0.5%1.26K+0.4%1.25K+1.9%
Additional paid-in capital30.4M+1.2%30.0M+6.6%28.2M+6.6%26.4M+5.0%25.2M+6.3%
Retained earnings64.2M+13.1%56.8M+31.3%43.3M-8.5%47.3M+0.6%47.0M+24.8%
Accumulated other comprehensive income
————17.0K-54.1%
Total liabilities & equity109M+10.6%98.3M+6.7%92.2M+7.8%85.5M+3.2%82.9M+16.6%
Common shares issued12.8M+0.6%12.7M+0.4%12.7M+0.6%12.6M+0.4%12.5M+1.9%
Common shares outstanding12.8M+0.6%12.7M+0.4%12.7M+0.6%12.6M+0.4%12.5M+1.9%
Shares outstanding (cover)12.8M+0.5%12.7M+0.4%12.7M+0.6%12.6M+0.3%12.6M+2.0%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
24.9M-2.6%25.6M+90.3%13.5M+34.1%10.0M-10.8%11.3M+93.5%
Depreciation & amortization1.17M+42.5%818K+6.9%765K+14.1%671K-52.3%1.41M+5.1%
Intangible amortization370K+59.5%232K+98.2%117K+15.7%101K-0.6%102K+9.5%
Share-based compensation2.92M+15.6%2.52M+15.4%2.19M+56.9%1.39M-4.5%1.46M-63.2%
Deferred income taxes2.73M+490.7%-698K+50.9%-1.42M-2307.6%64.4K-87.0%495K+27.1%
Change in receivables3.03M+271.8%-1.76M-109.3%-842K-110.2%8.24M+1331.8%576K+121.4%
Change in inventory1.38M+144.0%-3.13M-141.9%7.47M+470.5%1.31M+232.8%393K+39.0%
Change in payables-76.0K+91.2%-862K-298.3%-216K-119.2%1.12M+3598.9%30.4K+107.5%
-8.42M+4.5%-8.82M-10.1%-8.01M-482.3%-1.37M-312.1%648K+162.5%
Capital expenditure7.76M-3.0%8.01M+7.6%7.44M+804.1%823K+70.6%482K+8.9%
Free cash flow17.2M-2.5%17.6M+192.5%6.02M-34.7%9.22M-14.4%10.8M+100.5%
Acquisitions0.000.000.000.000.00
Sales/maturities of investments———500K-64.0%1.39M+57.3%
-17.6M-22.8%-14.3M-5.0%-13.7M-7.5%-12.7M-52122.1%24.4K-95.3%
Long-term debt issued0.000.000.000.000.00
Long-term debt repaid0.000.000.000.000.00
Common stock issued0.000.000.000.000.00
Common stock repurchased0.000.000.000.000.00
Dividends paid15.0M+10.0%13.7M+3.4%13.2M+5.3%12.6M0.00
Net change in cash-1.07M-143.5%2.47M+130.2%-8.20M-103.0%-4.04M-133.9%11.9M+81.1%
Income taxes paid3.92M-39.8%6.51M+21.7%5.35M+212.7%1.71M+76.4%970K
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap1.24B+77.8%699M+16.9%598M+68.3%356M-38.7%580M+106.8%
P/E55.3×+52.1%36.4×-0.8%36.7×+34.5%27.2×-56.2%62.2×-69.6%
P/S14.8×+55.4%9.5×+0.5%9.5×+34.5%7.1×-49.1%13.9×+56.8%
P/B13.1×+63.2%8.1×+0.4%8.0×+57.5%5.1×-36.6%8.0×+75.9%
P/FCF72.4×+82.3%39.7×-64.0%110.3×+201.4%36.6×-32.0%53.9×+3.1%
Earnings yield1.8%-34.3%2.8%+0.8%2.7%-25.7%3.7%+128.4%1.6%+229.5%
FCF yield1.4%-45.2%2.5%+177.9%0.91%-66.8%2.7%+47.2%1.9%-3.0%
Dividend yield1.2%-38.2%2.0%-11.1%2.2%-37.6%3.5%—
Source filing10-K10-K/A10-K10-K10-K

About this data

Source: IRMD’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all IRMD filings on SEC EDGAR → Not investment advice.